66834-87-5 Usage
Uses
Used in Pharmaceutical Industry:
(4aR,5S,7R,8aR)-7-methyl-5-[(2S)-piperidin-2-ylmethyl]decahydroquinoline is used as a potential drug candidate for the development of new pharmaceuticals due to its unique structure and biological activity. Its presence in natural products and the commonality of the piperidine moiety in many drugs suggest that it may have therapeutic applications.
Used in Bioactive Compound Research:
In the field of bioactive compound research, (4aR,5S,7R,8aR)-7-methyl-5-[(2S)-piperidin-2-ylmethyl]decahydroquinoline serves as a valuable scaffold for exploring new molecular entities with potential applications in medicine. Its specific stereochemistry and the presence of a methyl group may offer insights into the design of more effective and targeted therapeutic agents.
Used in Drug Design and Development:
(4aR,5S,7R,8aR)-7-methyl-5-[(2S)-piperidin-2-ylmethyl]decahydroquinoline is utilized in drug design and development as a template for creating novel compounds with improved pharmacological properties. Its unique structure and the potential for modification through chemical synthesis make it an attractive starting point for the development of new drugs with enhanced efficacy and selectivity.
Check Digit Verification of cas no
The CAS Registry Mumber 66834-87-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,6,8,3 and 4 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 66834-87:
(7*6)+(6*6)+(5*8)+(4*3)+(3*4)+(2*8)+(1*7)=165
165 % 10 = 5
So 66834-87-5 is a valid CAS Registry Number.
66834-87-5Relevant academic research and scientific papers
Asymmetric synthesis of all the known phlegmarine alkaloids
Wolfe, Bradley H.,Libby, Adam H.,Al-Awar, Rima S.,Foti, Christopher J.,Comins, Daniel L.
experimental part, p. 8564 - 8570 (2011/03/19)
The asymmetric synthesis of all four of the known natural phlegmarines and one synthetic derivative has been accomplished in 19-22 steps from 4-methoxy-3-(triisopropylsilyl)pyridine. Chiral N-acylpyridinium salt chemistry was used twice to set the stereoc
